NCT04083599 2026-04-08
GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
Genmab
Phase 1/2 Active not recruiting
Genmab
Tyligand Pharmaceuticals (Suzhou) Limited
Genfleet Therapeutics (Shanghai) Inc.
ImmunityBio, Inc.